News
With biologics making up about 40% of the global pipeline coupled with the rise in demand for cell and gene therapies, it is no secret the biopharma industry will need an influx of talent to meet its future workforce needs. This summer, 12 organizations had a chance to connect directly with 13 rising sophomores and juniors to begin building that...